Member Info for Northseatiger1

Thanks for being honest. I hope you get to grips with your vices. I've had a few myself in the past. Onwards and upwards. Hopefully OO will do the same for us all.

Strictly you went from ramping to deramping last year based on your investment in OO. I remember it all. Now I apologise if this upsets you but I am only speaking the truth.

And down she goes again.

2 billion dollar companies in the making? Everything priced all in wouldnt even make 1. Live and learn I suppose.

Signed.... Conman lol

Exactly Barwick. Adding along the way on 2 years of promises made by CF which havent materialised as if yet.

Well I have held here for nearly 2 years and I'm no longer in profit. No dividends, no 1 for 1 shares in any spin outs. No Nasdaq listing, Nothing. Just BS and some 3:1 shares that are still worthless to me.

https://www.reuters.com/business/healthcare-pharmaceuticals/worlds-first-covid-human-challenge-trial-found-be-safe-young-adults-2022-02-02/?taid=61fa3b3070fd090001a7942e&utm_campaign=trueAnthem:+Trending+Content&utm_medium=trueAnthem&utm_source=twitter

Is that because Theresa May and her husband are main shareholders in GW Pharmaceuticals. one of the biggest cannabis cultivators in the world? Didnt you know?

Scratch that. Just seen it was on the other BB

What RNS?

Check out the RNS over at Open Orphan. It could mean good new for holders of ABDX regarding testing. I am of holder of both. GLA

Probably. Did Cathals investment company lose 185k then? I've lost 3k. Luckily I restrained fron putting in more

Extrader? Don't you mean TW? That's been the word on the street for months ;)

It sure is. Orph was 16p in june/july 2020 wtf?!

How much further can this go? Looks like either LTHs or IIs are exiting here.

Jesus this sp is mental

Reasons trader? or simply deramping?

Dont worry. they havent paid their bill to Open Orphan either. They managed to pay their mates fine though. BTW I'm a holder of both shares. GLA

https://www.pneumagen.com/news/30/70/Pneumagen-Raises-3.8-million-to-Advance-the-Phase-II-Clinical-Development-of-Neumifil-a-Pan-antiviral-Intranasal-Drug-for-the-Prophylaxis-and-Treatment-of-Viral-Respiratory-Tract-Infections-RTIs.html